Page 62 - Toksoplazmoz Tanı ve Tedavi Uzlaşı Raporu

Toksoplazmoz Tanı ve Tedavi Uzlaşı Raporu

KaynaKlaR 19. Jakobs L, Remington JS, Melton ML. The resistance of the encysted
form of Toxoplasma gondii. J Parasitol 1960;46:11-21. https://doi.
1. Akstein RB, Wilson LA, Teutsch SM. Acquired toxoplasmosis. Ophthalmol org/10.2307/3275325
1982;89:1299-302. https://doi.org/10.1016/S0161-6420(82)34629-1
20. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB.
2. Ammar F, Mahjoub A, Ben Abdesslam N, Knani L, Ghorbel M, Mahjoub H. Toxoplasma gondii infection in the United States: Seroprevalence and
Spectral optical coherence tomography findings in patients with ocular risk factors. Am J Epidemiol 2001;154(4):357-65. https://doi.org/10.1093/
toxoplasmosis: A case series study.Ann Med Surg (Lond) 2020,24;54:125- aje/154.4.357
8. https://doi.org/10.1016/j.amsu.2020.04.008
21. Katlama C, De Wit S, O’Doherty E, Van Glabeke M, Clumeck N. Pyrimeth-
3. Awan KJ. Congenital toxoplasmosis: Chances of occurence in subse- amine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-
quent siblings. Ann Ophthalmol 1978;10:459-65. term therapy for toxoplasmic encephalitis in patients with AIDS. Clin
4. Ben Yahia S, Herbort CP, Jenzeri S, Hmidi K, Attia S, Messaoud R, et al. Infect Dis 1996;22:268-75. https://doi.org/10.1093/clinids/22.2.268
Intravitreal bevacizumab (Avastin) as primary and rescue treatment 22. Kim P, Younan N, Coroneo MT. Hypersensitivity reaction to intravitreal
for choroidal neovascularization secondary to ocular toxoplasmosis. clindamycin therapy. Clin Experiment Ophthalmol 2002;147-8. https://
Int Ophthalmol 2008;28(4):311-6. https://doi.org/10.1007/s10792-008- doi.org/10.1046/j.1442-6404.2002.00502.x
9218-2
23. Kishore K, Conway MD, Peyman GA. Intravitreal clindamycin and dex-
5. Ben Zina Z, Abid D, Kharrat W, Chaker N, Aloulou K, Chaabouni M. Inter- amethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg Lasers
est in treatment with subconjunctival clindamycin in toxoplasmic retin- 2001;32:183-92. https://doi.org/10.3928/1542-8877-20010501-03
ochoroiditis. Tunis Med 2001;79:157-60.
24. Labalette P, Delhaes L, Margaron F, Fortier B, Rouland JF. Ocular toxo-
6. BenEzra D. Toxoplasmosis. In Ocular inflammation basic and clinical plasmosis after the fifth decade. Am J Ophthalmol 2002;133(4):506-15.
concepts BenEzra D. ed. London Martin Dunitz Ltd 1999;393-411. https://doi.org/10.1016/S0002-9394(02)01324-7
7. Beverley JKA. A new look at Infectious Diseases: Toxoplasmosis. Br Med J 25. Langer H. Repeated congenital infection with Toxoplasma gondii. Ob-
1973;2:475-8. https://doi.org/10.1136/bmj.2.5864.475 stet Gynecol 1963;21:318-23.
8. Beverley JKA. Congenital Toxoplasma infections. Proc Roy Soc Med 26. Levine ND, Nye RR. Toxoplasma ranae sp from the leopard frog
1960;53:111. Fish RH, Hoskins JC, Kline LB. Toxoplasmosis neuroreti- Rana pipiens Linnaeus. Protozool 1976;23:488-90. https://doi.
nitis. Ophthalmol 1993;100:1177-82. https://doi.org/10.1016/S0161- org/10.1111/j.1550-7408.1976.tb03821.x
6420(13)31511-5
27. Masur H, Jones TC, Lempert JA, Cherubini TD. Outbreak of toxoplasmosis
9. Bosch-Driessen LH, Verbraak FD, Suttorp-Schulten MS, van Ruyven RL, in a family and documentation of acquired retinochoroiditis. Am J Med
Klok AM, Hoyng C. A prospective, randomized trial of pyrimethamine 1978;64:396-402. https://doi.org/10.1016/0002-9343(78)90218-8
and azithromycin vs pyrimethamine and sulfadiazine for the treatment
of ocular toxoplasmosis. Am J Ophthalmol 2002;134(1):34-40. https:// 28. Mirza GE. Paraziter uveitler. TOD Ankara Şubesi Akademik Eğitim Pro-
doi.org/10.1016/S0002-9394(02)01537-4 gramı 23. Ulusal Oftalmoloji Kursu. Uvea hastalıkları ve tedavisi. Ankara
Şen Matbaa 2003;190-6.
10. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular
toxoplasmosis: Clinical features and prognosis of 154 patients. Ophthal- 29. Moreno RJ, Weisman J, Waller S. Neuroretinitis: An unusual presentation
mol 2002;109:869-78. https://doi.org/10.1016/S0161-6420(02)00990-9 of ocular toxoplasmosis. Ann Ophthalmol 1992;24:68-70.
30. Opremcak EM, Scales DK, Sharpe MR. Trimethoprim-sulfamethoxazole
11. Bosch-Driessen LH, Plaisier MB, Stilma JS, Van der Lelij A, Rothova A. Re-
activations of ocular toxoplasmosis after cataract extraction. Ophthal- therapy for ocular toxoplasmosis. Ophthalmol 1992;99:920-5. https://
mol 2002;109:41-5. https://doi.org/10.1016/S0161-6420(01)00845-4 doi.org/10.1016/S0161-6420(92)31873-1
31. Pavesio CE, Lightman S. Toxoplasma gondii and ocular toxoplasmo-
12. Bowie WR, King AS, Werker DH, Isaac-Renton JL, Bell A, Eng SB, et al. sis: Pathogenesis. British J Ophthalmol 1996;80:1099-107. https://doi.
Outbreak of toxoplasmosis associated with municipal drinking water. org/10.1136/bjo.80.12.1099
The BC Toxoplasma Investigation Team. Lancet 1997;350(9072):173-7.
https://doi.org/10.1016/S0140-6736(96)11105-3 32. Pavesio C. Parasitic infections. In Uveitis text and imaging Gupta A, Gup-
ta V, Herbort CP, Khairallah M. eds. New Delhi JAYPEE Brothers Medical
13. Britt RH, Enzmann DR, Remington JS. Intracranial infection in car- Publishers Ltd 2009:661-72.
diac transplant recipients. Ann Neurol 1981;9:107-19. https://doi.
org/10.1002/ana.410090203 33. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 1973;57:1-17. https://
doi.org/10.1136/bjo.57.1.1
14. Desmonts G, Couvrer J. Congenital toxoplasmosis. A prospective study of
378 pregnancies. N Engl J Med 1974;290:1110-6. https://doi.org/10.1056/ 34. Remington JS, Jacobs L, Melton ML, Kaufman HE. Chronic toxoplas-
NEJM197405162902003 ma infection in a human uterus. J Parasitol 1958;44:587. https://doi.
org/10.2307/3274539
15. Garweg JG, Kodjikian L, Peyron F, Binquet C, Fleury J, Grange JD, et al.
Congenital ocular toxoplasmosis- ocular manifestations and prog- 35. Rothova A, Meenken C, Buitenhuis HJ, Brinkman CJ, Baarsma GS,
nosis after early diagnosis of infection. Klin Monatsbl Augenheilkd Boen-Tan TN, et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol
2005;222:721-7. https://doi.org/10.1055/s-2005-858615 1993;115:517-23. https://doi.org/10.1016/S0002-9394(14)74456-3
16. Gump DW, Holden RA. Acquired chorioretinitis due to toxoplasmosis. 36. Rothova A. Ocular manifestations of toxoplasmosis. Curr Opin Oph-
Ann Intern Med 1979;90:58-60. https://doi.org/10.7326/0003-4819-90- thalmol 2003;14:384-8. https://doi.org/10.1097/00055735-200312000-
1-58 00011
17. Güngör SG, Akkoyun İ, Şimgar E, Yılmaz G. Intravitreal bevacizumab in- 37. Sari M, Vuorre I, Neiminen H. Acquired toxoplasmosis chorioretini-
jection therapy in a case with choroidal neovascular membrane second- tis. Arch Ophthalmol 1976;94:1485-8. https://doi.org/10.1001/ar-
ary to toxoplasmosis retinochoroiditis. Turk J Ophthalmol 2014;44:237- chopht.1976.03910040319005
9. 38. Siegel SE, Lunde MN, Gelderman AH, Halterman RH, Brown JA, Levine
18. Holland GN, Engstrom RE Jr, Glasgow BJ, Berger BB, Daniels SA, Sidikaro AS, et al. Transmission of toxoplasmosis by leukocyte transfusion. Blood
Y, et al. Ocular toxoplasmosis in patients with the acquired immunode- 1971;37(4):388-94. https://doi.org/10.1182/blood.V37.4.388.388
ficiency syndrome. Am J Ophthalmol 1988;106(6):653-67. https://doi.
org/10.1016/0002-9394(88)90697-6

53